Kyle G. McClements CFA Net Worth

The estimated Net Worth of Kyle Mc Clements is at least $346 ezer dollars as of 31 January 2024. Mr Clements owns over 753 units of BlackRock Health Sciences Trust stock worth over $293,419 and over the last 19 years he sold BME stock worth over $52,787.

Mr CFA BME stock SEC Form 4 insiders trading

Mr has made over 85 trades of the BlackRock Health Sciences Trust stock since 2005, according to the Form 4 filled with the SEC. Most recently he exercised 753 units of BME stock worth $31,754 on 31 January 2024.

The largest trade he's ever made was exercising 6,456 units of BlackRock Health Sciences Trust stock on 31 January 2020 worth over $272,250. On average, Mr trades about 1,380 units every 62 days since 2005. As of 31 January 2024 he still owns at least 6,958 units of BlackRock Health Sciences Trust stock.

You can see the complete history of Mr Clements stock trades at the bottom of the page.

Mr. Kyle G. McClements CFA biography

Kyle G. McClements CFA is the Portfolio Mang. at BlackRock Health Sciences Trust.

Insiders trading at BlackRock Health Sciences Trust

Over the last 20 years, insiders at BlackRock Health Sciences Trust have traded over $27,424 worth of BlackRock Health Sciences Trust stock and bought 5,012 units worth $181,509 . The most active insiders traders include Ralph Schlosstein, Jerrold B Harris és Karen P Robards. On average, BlackRock Health Sciences Trust executives and independent directors trade stock every 203 days with the average trade being worth of $147,131. The most recent stock trade was executed by Kyle Mc Clements on 31 January 2024, trading 625 units of BME stock currently worth $26,356.

What does BlackRock Health Sciences Trust do?

blackrock's business is investing on behalf of our clients, from large institutions to parents and grandparents, doctors and teachers who entrust their savings to us. we work only for our clients—period. our promise is to offer them the clearest thinking about what to do with their money and the products and services they need to secure a better financial future. that's why investors of all kinds have made us the world’s largest asset manager, entrusting us with trillions of dollars, and it’s why companies, institutions and global governments come to us for help meeting their biggest financial challenges. important disclosures: http://www.blackrock.com/corporate/en-us/compliance/social-media-guidelines

Complete history of Mr Clements stock trades at Blackrock & Resources Trust, BlackRock Enhanced International Dividend Trust, BlackRock Enhanced Global Dividend Trust, BlackRock Utility Infrastructure & Power Opportunities Trust, BlackRock Enhanced Capital and Income Fund Inc, BlackRock Enhanced Equity Dividend Trust, BlackRock Health Sciences Trust, BlackRock Science and Technology Trust, BlackRock Resources & Commodities Strategy Trust, BlackRock Health Sciences Term Trust és BlackRock Science and Technology Term Trust

BlackRock Health Sciences Trust executives and stock owners

BlackRock Health Sciences Trust executives and other stock owners filed with the SEC include:

• Dr. Erin Xie Ph.D.,
  Portfolio Mang.
• Thomas P. Callan C.F.A.,
  Portfolio Mang.
• Dr. Xiang Liu Ph.D.,
  Portfolio Mang.
• Jeffrey Gene Lee,
  Portfolio Mang.
• Christopher M. Accettella,
  Portfolio Mang.
• Dr. Erin Xie,
  Portfolio Mang.
• Kyle G. McClements CFA,
  Portfolio Mang.
• Thomas P. Callan C.F.A., CFA,
  Portfolio Mang.
• Charles Choon Sik Park,
  Chief Compliance Officer and Anti-Money Laundering Officer
• Xiang Liu,
  
• Jerrold B Harris,
  Director
• Richard Cavanagh,
  Director
• Robert Glenn Hubbard,
  Director
• Christopher Accettella,
  
• Michael J Castellano,
  Director
• Catherine A. Lynch,
  Director
• Karen P Robards,
  Director
• Kyle Mc Clements,
  
• H Erin Xie,
  
• W Carl Kester,
  Director
• James Laforce,
  Director
• Walter F Mondale,
  Director
• Ralph Schlosstein,
  Director
• Frank Fabozzi,
  Director
• Kathleen F Feldstein,
  Director
• James T Flynn,
  Director
• George Nicholas Iii Beckwith,
  Director
• Robert Kapito,
  President & CEO of the Trust
• Henry Gabbay,
  Director
• Dick Davis,
  Director
• Kent Dixon,
  Director
• Cynthia Egan,
  Director
• Jeffrey Gene Lee,